Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

BioMarin Pharmaceutical

BioMarin Pharmaceutical reported $598.23M in Current Liabilities for its fiscal quarter ending in March of 2023.

Current Liabilities Change
Acadia Pharmaceuticals ACAD:US USD 224.3M 98.67M
Acorda Therapeutics ACOR:US USD 34.74M 3.21M
Agios Pharmaceuticals AGIO:US USD 45.11M 17.52M
Alnylam Pharmaceuticals ALNY:US USD 673.39M 94.52M
Amgen AMGN:US USD 14.22B 1.47B
Bayer BAYN:GR EUR 34.39B 693M
Biogen BIIB:US USD 3.01B 257.9M
BioMarin Pharmaceutical BMRN:US USD 598.23M 9.35M
Bluebird Bio BLUE:US USD 115.93M 12.3M
Gilead Sciences GILD:US USD 10.53B 709M
Incyte Corp INCY:US USD 1.01B 150.97M
Insmed INSM:US USD 187.98M 2.26M
Intercept Pharmaceuticals ICPT:US USD 207.12M 22.96M
Ionis Pharmaceuticals IONS:US USD 259.22M 52.34M
Moderna Inc MRNA:US USD 3.5B 1.42B
Neurocrine Biosciences NBIX:US USD 374.1M 163.6M
PTC Therapeutics PTCT:US USD 441.63M 35.4M
Puma Biotechnology PBYI:US USD 48.19M 29.3M
Regeneron Pharmaceuticals REGN:US USD 3.1B 41.2M
Roche Holding ROG:VX CHF 27.24B 170M
Sangamo BioSciences SGMO:US USD 57.84M 53.87M
Sarepta Therapeutics SRPT:US USD 536.88M 82.72M
Seattle Genetics SGEN:US USD 713.23M 105.18M
Ultragenyx Pharmaceutical RARE:US USD 218.18M 43.03M
United Therapeutics UTHR:US USD 324.6M 18.6M
Vertex Pharmaceuticals VRTX:US USD 3.03B 284.1M